Proxy Results (Form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.

On September 3, 2026, Co-Diagnostics, Inc. (the "Company") held its previously announced Annual Meeting of Stockholders (the "Annual Meeting"). However, the Company did not achieve a quorum and therefore was unable to transact business at the meeting.

Pursuant to the Company's bylaws, if a quorum is not present or represented at any meeting of the stockholders, the chairperson of the meeting has the power to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is present or represented. Accordingly, the Annual Meeting was adjourned to September 24, 2026, at 9:00 a.m. Mountain Time. The adjourned meeting will be held at the Company's offices located at 2401 S. Foothill Dr, Ste. D, Salt Lake City, Utah 84109.

At the adjourned Annual Meeting on September 24, 2026, stockholders will be deemed to be present in person and vote at such adjourned meeting in the same manner as disclosed in the definitive proxy statement the Company filed with the Securities and Exchange Commission on July 21, 2026. Valid proxies submitted prior to the reconvened Annual Meeting will continue to be valid for the upcoming reconvened Annual Meeting, unless properly changed or revoked prior to votes being taken at such reconvened Annual Meeting.